STEVEN C QUAY
CIK 1008227 · President & CEO · last filed 2026-01-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$59.13M
Companies
3
Total Filings
32
Lifetime Open-Market Net
-$431.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ATOS | President & CEO | 367,826 | $2.46 | $904.9K | -$7.7K | 21 | 2026-01-30 |
| MRNA | Chairman and CSO | 1,166,669 | $49.91 | $58.23M | $0 | 2 | 2009-03-20 |
| Adhera Therapeutics, Inc. (NSTK) Delisted | Chairman and CEO | 434,624 | — | — | -$424.0K | 9 | 2008-04-02 |
Recent Filings · Page 3 of 4
32 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-03-13 | ATOS | Grant (A) | — | $0 | EDGAR |
| 2009-03-20 | MRNA | Mixed | +731,275 | $0 | EDGAR |
| 2008-06-12 | MRNA | Grant (A) | — | $0 | EDGAR |
| 2008-04-02 | Adhera Therapeutics, Inc. (NSTK) Delisted | Other (J) | +3,500 | $7.0K | EDGAR |
| 2007-09-28 | Adhera Therapeutics, Inc. (NSTK) Delisted | Sell (S) | −5,200 | -$70.9K | EDGAR |
| 2007-07-27 | Adhera Therapeutics, Inc. (NSTK) Delisted | Sell (S) | −5,800 | -$70.8K | EDGAR |
| 2007-07-23 | Adhera Therapeutics, Inc. (NSTK) Delisted | Tax (F) | −11,103 | -$140.0K | EDGAR |
| 2007-06-08 | Adhera Therapeutics, Inc. (NSTK) Delisted | Sell (S) | −6,400 | -$70.9K | EDGAR |
| 2007-04-20 | Adhera Therapeutics, Inc. (NSTK) Delisted | Sell (S) | −5,850 | -$70.4K | EDGAR |
| 2007-03-01 | Adhera Therapeutics, Inc. (NSTK) Delisted | Sell (S) | −6,130 | -$70.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.